North America Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By  Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery); Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory. Diseases, Central Nervous System Disorders, Autoimmune Diseases, and Other Diseases); End User (Hospitals, Home Care Settings, ASC/Clinics, Other End Users); and Country

TIPRE00011595 | Pages: 145 | Pharmaceuticals | Jun 2020 | Type: Regional | Status: Published

Market Introduction

Drug delivery is an engineered technology that is implemented in medical devices to inject drugs or chemicals into the body. These technologies are used to enhance efficacy, drug absorption, and recovery rate. A few types of the drug delivery systems available in the market include transmucosal, oral, pulmonary, injectable, topical, nasal, implantable, and ocular. Drug delivery systems are primarily used to control the rate of drug release or targeted delivery of various therapeutic agents to treat multiple diseases or improve the health of the patients.


Get more information on this report :



Market Overview and Dynamics

The North America pharmaceutical drug delivery market is expected to reach US$ 9,36,148.9 Mn by 2027 from US$  5,60,491.5 Mn in 2019. The market is anticipated to grow at a CAGR of 6.8% during 2020–2027. Increasing prevalence of chronic diseases is a prime factor driving the market growth. However, the high cost associated with drug delivery device development restrains the market growth.

Key Market Segments

In terms of the route of administration, the injectable drug delivery segment accounted for the largest share of the North American pharmaceutical drug delivery market in 2018. In terms of application, the cancer segment held the largest market share of the market in 2019. In terms of end users, the hospitals segment held the most significant share of the market in 2018.

Major Sources and Companies Listed

A few of the major primary and secondary sources referred to while building this report on the North America pharmaceutical drug delivery market are the Centers For Disease Control And Prevention (CDC), Food and Drug Administration (FDA), Ministry of Health and Prevention (MoHAP), Ministry of Health and Family Welfare (MoHFW), and American Cancer Society (ACS).

Reasons to buy report

  • It provides understanding of the North America, push to talk market landscape and identifies market segments that are most likely to guarantee a strong return.
  • It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the North America push to talk market.
  • It helps efficiently plan merger and acquisition, and partnership deals in the North America pharmaceutical drug delivery market by identifying market segments with the most promising probable sales
  • It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of market performance of various segments pertaining to the North America push to talk market.
  • It provides market revenue forecast of the market based on various segments for the period from 2018 to 2027.

NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET SEGMENTATION

By Route of Administration

  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Nasal Drug Delivery
  • Transmucosal Drug Delivery
  • Implantable Drug Delivery

 

By Application

  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Autoimmune Diseases
  • Other Applications

 

By End User

  • Hospitals
  • Home Care Settings
  • ASC/Clinics
  • Other End Users

 

By Country

  • North America
    • US
    • Canada
    • Mexico

 

Company Profiles

  • 3M
  • Antares Pharma
  • BD
  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.

 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Pharmaceutical Drug Delivery Market – By Route of Administration

1.3.2        North America Pharmaceutical Drug Delivery Market – By Application

1.3.3        North America Pharmaceutical Drug Delivery Market – By End User

1.3.4        North America Pharmaceutical Drug Delivery Market – By Country

2.           North America Pharmaceutical Drug Delivery Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Pharmaceutical Drug Delivery Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        4.2.1 North America Pharmaceutical Drug Delivery Market - North America PEST Analysis

4.3         Expert Opinion

5.           North America Pharmaceutical Drug Delivery Market - Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Increasing Prevalence of Chronic Diseases

5.2         Key Restraints

5.2.1        High Cost of Drug Delivery Device Development

5.3         Key Market Opportunities

5.3.1        Increasing R&D Spending for Drug Delivery Devices

5.4         Future Trend

5.4.1        Growth in Drug Delivery Technology and Innovations

5.5         Impact Analysis

6.           Pharmaceutical Drug Delivery Market – North America Analysis

6.1         North America Pharmaceutical Drug Delivery Market Revenue Forecasts and Analysis

6.2         Market Positioning of Key Players

7.           Pharmaceutical Drug Delivery Market Analysis – By Route of Administration

7.1         Overview

7.2         North America Pharmaceutical Drug Delivery Market Revenue Share, by Route of Administration (2019 and 2027)

7.3         Oral Drug Delivery

7.3.1        Overview

7.3.2        Oral Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Injectable Drug Delivery

7.4.1        Overview

7.4.2        Injectable Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027  (US$ Million)

7.5         Topical Drug Delivery

7.5.1        Overview

7.5.2        Topical Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027  (US$ Million)

7.6         Ocular Drug Delivery

7.6.1        Overview

7.6.2        Ocular Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027  (US$ Million)

7.7         Pulmonary Drug Delivery

7.7.1        Overview

7.7.2        Pulmonary Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027  (US$ Million)

7.8         Nasal Drug Delivery

7.8.1        Overview

7.8.2        Nasal Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

7.9         Transmucosal Drug Delivery

7.9.1        Overview

7.9.2        Transmucosal Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027  (US$ Million)

7.10      Implantable Drug Delivery

7.10.1     Overview

7.10.2     Implantable Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027  (US$ Million)

8.           Pharmaceutical Drug Delivery Market Analysis –  By Application

8.1         Overview

8.2         North America Pharmaceutical Drug Delivery Market Revenue Share, by Application (2019 and 2027)

8.3         Infectious Diseases

8.3.1        Overview

8.3.2        Infectious Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Cancer

8.4.1        Overview

8.4.2        Cancer: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Cardiovascular Diseases

8.5.1        Overview

8.5.2        Cardiovascular Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027  (US$ Million)

8.6         Diabetes

8.6.1        Overview

8.6.2        Diabetes: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.7         Respiratory Diseases

8.7.1        Overview

8.7.2        Respiratory Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027  (US$ Million)

8.8         Central Nervous System Disorders

8.8.1        Overview

8.8.2        Central Nervous Systems Disorders: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.9         Autoimmune Diseases

8.9.1        Overview

8.9.2        Autoimmune Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027  (US$ Million)

8.10      Other Diseases

8.10.1     Overview

8.10.2     Other Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.           Pharmaceutical Drug Delivery Market Analysis –  By End User

9.1         Overview

9.2         North America Pharmaceutical Drug Delivery Market Share, by End User, 2019 and 2027, (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.4         Home Care Settings

9.4.1        Overview

9.4.2        Home Care Settings: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.5         ASCs/ Clinics

9.5.1        Overview

9.5.2        ASCs/ Clinics: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.6         Other End Users

9.6.1        Overview

9.6.2        Other End Users: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.        Pharmaceutical Drug Delivery Market Revenue and Forecasts To 2027 – Geographical Analysis

10.1      North America Pharmaceutical Drug Delivery Market Revenue and Forecasts To 2027

10.1.1     Overview

10.1.2     North America: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.3     North America Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

10.1.4     North America Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.5     North America Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027  (USD Million)

10.1.6     North America: Pharmaceutical Drug Delivery Market, by Country, 2019 & 2027 (%)

10.1.7     US: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       US: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       US Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

10.1.7.3       US Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.7.4       US Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.8     Canada: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       Canada: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       Canada Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

10.1.8.3       Canada Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.8.4       Canada Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.9     Mexico: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1       Mexico: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2       Mexico Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

10.1.9.3       Mexico Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.9.4       Mexico Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.        Impact of COVID-19 Pandemic on Global Pharmaceutical Drug Delivery Market

11.1      North America: Impact Assessment of COVID-19 Pandemic

12.        Company Profiles

12.1      3M

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Antares Pharma

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      BD

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Pfizer Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Johnson & Johnson Services, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             North America Pharmaceutical Drug Delivery Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 2.             North America Pharmaceutical Drug Delivery Market, by Application– Revenue and Forecast to 2027  (USD Million)

Table 3.             North America Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 4.             US Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 5.             US Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 6.             US Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7.             Canada Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 8.             Canada Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.             Canada Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 10.          Mexico Pharmaceutical Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 11.          Mexico Pharmaceutical Drug Delivery Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 12.          Mexico Pharmaceutical Drug Delivery Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.          Glossary of Terms, Pharmaceutical Drug Delivery Market

 


LIST OF FIGURES

Figure 1.           Pharmaceutical Drug Delivery Market Segmentation

Figure 2.           North America Pharmaceutical Drug Delivery Market Overview

Figure 3.           Injectable Drug Delivery Segment Held Largest Share of Product Segment in Pharmaceutical Drug Delivery Market

Figure 4.           US Is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           North America Pharmaceutical Drug Delivery Market- Leading Country Markets (US$ Mn)

Figure 6.           North America Pharmaceutical Drug Delivery Market, Industry Landscape

Figure 7.           North America Pharmaceutical Drug Delivery Market - North America PEST Analysis

Figure 8.           Pharmaceutical Drug Delivery Market Impact Analysis of Drivers and Restraints

Figure 9.           North America Pharmaceutical Drug Delivery Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 10.        Market Positioning Of Key Players In Global Pharmaceutical Drug Delivery Market

Figure 11.        North America Pharmaceutical Drug Delivery Market Revenue Share, by Route of Administration (2019 and 2027)

Figure 12.        Oral Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Injectable Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Topical Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Ocular Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Pulmonary Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Nasal Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Transmucosal Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027  (US$ Million)

Figure 19.        Implantable Drug Delivery: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        North America Pharmaceutical Drug Delivery Market Revenue Share, by Application (2019 and 2027)

Figure 21.        Infectious Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Cancer: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Cardiovascular Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Diabetes: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Respiratory Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Central Nervous Systems Disorders: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Autoimmune Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Other Diseases: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        North America Pharmaceutical Drug Delivery Market Share, by End User, 2019 and 2027 (%)

Figure 30.        Hospitals: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 31.        Home Care Settings: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 32.        ASCs/ Clinics: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 33.        Other End Users: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 34.        North America: Pharmaceutical Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)

Figure 35.        North America Pharmaceutical Drug Delivery Market Revenue and Forecast to 2027 (USD Million)

Figure 36.        North America: Pharmaceutical Drug Delivery Market, by Country, 2019 & 2027 (%)

Figure 37.        US: Pharmaceutical Drug Delivery market – Revenue and Forecast to 2027 (USD Million)

Figure 38.        Canada: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 39.        Mexico: Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 40.        Impact of COVID-19 Pandemic in North American Country Markets

The List of Companies - North America Pharmaceutical Drug Delivery Market

  1. 3M
  2. Antares Pharma
  3. BD
  4. Pfizer Inc.
  5. Johnson & Johnson Services, Inc.

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America pharmaceutical drug delivery market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the North America pharmaceutical drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000